Septodont has announced a strategic investment in US-based Balanced Pharma, a dentist-founded pharmaceutical company with a focus on improved patient comfort and safety.
Balanced Pharma’s drugs currently in development are intended to improve upon current dental anaesthetic drugs with elegant design solutions that retain the standard cartridge, safety and efficacy profile, and shelf-life.
This investment underscores Septodont’s commitment to accelerating innovation and delivering benefits to patients and dentists without changing the means of administering anaesthesia.
As a recognised authority in dental anesthesia, Septodont is positioned to partner with Balanced Pharma and help dental practices to deliver superior patient experiences.
